Stockscreener 앱 받기
43.00
1.31%
-0.57
시간 외 거래:
43.00
전일 마감가:
$43.57
열려 있는:
$44.23
하루 거래량:
1.54M
Relative Volume:
0.49
시가총액:
$6.27B
수익:
$10.12M
순이익/손실:
$-280.49M
주가수익비율:
-14.88
EPS:
-2.89
순현금흐름:
$-188.51M
1주 성능:
-0.49%
1개월 성능:
-7.69%
6개월 성능:
+60.81%
1년 성능:
-11.36%
1일 변동 폭
$42.84
$45.00
1주일 범위
$38.94
$45.00
52주 변동 폭
$21.51
$56.00
어비디티 바이오사이언스 Stock (RNA) Company Profile
명칭
Avidity Biosciences Inc
전화
858-401-7900
주소
10578 SCIENCE CENTER DRIVE, SAN DIEGO, CA
RNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RNA
Avidity Biosciences Inc
|
43.00 | 6.36B | 10.12M | -280.49M | -188.51M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
404.21 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
599.94 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.65 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
767.33 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
335.16 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
어비디티 바이오사이언스 Stock (RNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 개시 | Roth Capital | Buy |
| 2025-07-10 | 재개 | Goldman | Buy |
| 2025-06-24 | 개시 | Bernstein | Outperform |
| 2025-06-17 | 개시 | Wolfe Research | Outperform |
| 2025-06-11 | 개시 | Raymond James | Strong Buy |
| 2025-03-13 | 개시 | Citigroup | Buy |
| 2025-03-12 | 개시 | BMO Capital Markets | Outperform |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-12-20 | 개시 | H.C. Wainwright | Buy |
| 2024-11-26 | 개시 | RBC Capital Mkts | Outperform |
| 2024-09-24 | 개시 | Goldman | Buy |
| 2024-08-28 | 개시 | Barclays | Overweight |
| 2024-05-03 | 개시 | BofA Securities | Buy |
| 2024-03-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-05-22 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-07-20 | 개시 | Chardan Capital Markets | Buy |
| 2022-07-12 | 개시 | Raymond James | Strong Buy |
| 2021-09-07 | 개시 | Evercore ISI | Outperform |
| 2021-06-17 | 개시 | Needham | Buy |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-07-07 | 개시 | Cowen | Outperform |
| 2020-07-07 | 개시 | Credit Suisse | Outperform |
| 2020-07-07 | 개시 | SVB Leerink | Outperform |
| 2020-07-07 | 개시 | Wells Fargo | Overweight |
모두보기
어비디티 바이오사이언스 주식(RNA)의 최신 뉴스
Avidity Biosciences Inc. stock trendline breakdownOptions Play & Free Expert Verified Stock Movement Alerts - newser.com
Ranking Avidity Biosciences Inc. among high performing stocks via tools2025 Price Targets & AI Driven Stock Movement Reports - newser.com
Can Avidity Biosciences Inc. hit a new high this month2025 Trading Recap & Risk Controlled Stock Alerts - newser.com
Relative strength of Avidity Biosciences Inc. in sector analysis2025 Price Action Summary & Fast Entry Momentum Alerts - newser.com
Avidity Biosciences (NASDAQ:RNA) Shares Down 7.6%Here's What Happened - MarketBeat
Can Avidity Biosciences Inc. stock hit record highs againJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
Quantitative breakdown of Avidity Biosciences Inc. recent moveInsider Selling & Verified Entry Point Signals - newser.com
Avidity Biosciences, Inc. (RNA) Stock Analysis: A Promising Biotech Play with 58.58% Potential Upside - DirectorsTalk Interviews
Avidity Biosciences, Inc. (RNA) Stock Analysis: A Potent 58.58% Upside In Biotech - DirectorsTalk Interviews
Combining machine learning predictions for Avidity Biosciences Inc.Portfolio Return Summary & Weekly High Return Stock Opportunities - newser.com
Real time scanner hits for Avidity Biosciences Inc. explainedJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Why Momentum Traders Are Watching Shigan Quantum Technologies Limited Stock CloselyDebt-to-Equity Ratio Analysis & Ride the Trends That Billionaires Follow - earlytimes.in
Assenagon Asset Management S.A. Has $507,000 Position in Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences (RNA) Announces Positive One-Year Data For its, Del-Zota - Yahoo Finance
Avidity Biosciences (NASDAQ:RNA) Insider Sells $89,600.64 in Stock - MarketBeat
Evercore Maintains Avidity Biosciences(RNA.US) With Buy Rating, Cuts Target Price to $65 - 富途牛牛
Analysts Issue Forecasts for RNA Q3 Earnings - MarketBeat
Avidity Biosciences Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Evercore ISI Group Lowers Price Target for Avidity Biosciences (RNA) to $65 | RNA Stock News - GuruFocus
Evercore ISI Cuts Avidity Biosciences (NASDAQ:RNA) Price Target to $65.00 - MarketBeat
Repare Therapeutics (NASDAQ:RPTX) versus Avidity Biosciences (NASDAQ:RNA) Head to Head Contrast - Defense World
Mirador Capital Partners LP Grows Stock Position in Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Coverage Initiated at Roth Capital - MarketBeat
Voya Investment Management LLC Cuts Stock Position in Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences prices $600M stock offering - MSN
Aug Big Picture: Can Avidity Biosciences Inc. maintain sales growth2025 Technical Patterns & Detailed Earnings Play Strategies - khodrobank.com
What is Roth Capital’s Estimate for RNA Q3 Earnings? - Defense World
Roth MKM Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $62 - 富途牛牛
First Week of November 21st Options Trading For Avidity Biosciences (RNA) - Nasdaq
Avidity Biosciences (NASDAQ:RNA) Stock Price Down 5.3%Here's What Happened - MarketBeat
Bank of America Increases Avidity Biosciences (NASDAQ:RNA) Price Target to $65.00 - MarketBeat
Investor Mood: Is Pamt Corp. currently under institutional pressureMarket Volume Summary & Weekly Watchlist of Top Performers - khodrobank.com
Analyst Calls: What hedge funds are buying Avidity Biosciences IncJuly 2025 Reactions & High Win Rate Trade Tips - خودرو بانک
Breakouts Watch: Should value investors consider Avidity Biosciences Inc2025 Dividend Review & Precise Swing Trade Alerts - khodrobank.com
Avidity (RNA) Jumps 9.2% on Drug Candidate’s Breakthrough Therapy Designation - MSN
Aug Mood: Will HRZN be affected by tariffs2025 Dividend Review & Daily Stock Momentum Reports - khodrobank.com
Aug Chart Watch: What makes Avidity Biosciences Inc. stock attractive todayTreasury Yields & Advanced Swing Trade Entry Plans - خودرو بانک
Avidity Biosciences’ SWOT analysis: promising pipeline drives stock outlook - Investing.com
Growth Value: Is Avidity Biosciences Inc. stock showing strong momentumJuly 2025 Breakouts & Free Safe Entry Trade Signal Reports - khodrobank.com
Roth Capital Initiates Coverage of Avidity Biosciences (RNA) with Buy Recommendation - Nasdaq
Avidity Biosciences CMO sells $70k in shares - Investing.com
Avidity Biosciences (RNA) Gets 9% Boost from Higher PT, Rating - MSN
Avidity Biosciences Stock Hits Day Low of $39.83 Amid Price Pressure - Markets Mojo
Roth Capital Initiates Coverage on RNA with a 'Buy' Rating | RNA Stock News - GuruFocus
Decliners Report: Can Avidity Biosciences Inc continue delivering strong returnsMarket Risk Analysis & Free Risk Controlled Daily Trade Plans - خودرو بانک
Roth Capital Partners Initiates Avidity Biosciences at Buy - MarketScreener
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Eastern Progress
Roth/MKM initiates Avidity Biosciences stock with Buy rating on platform potential - Investing.com
Avidity Biosciences (NASDAQ:RNA) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
어비디티 바이오사이언스 (RNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.95%
1.63%
자본화:
|
볼륨(24시간):